|Bid||131.83 x 1000|
|Ask||132.01 x 800|
|Day's Range||130.38 - 132.96|
|52 Week Range||110.51 - 170.75|
|Beta (5Y Monthly)||0.19|
|PE Ratio (TTM)||21.75|
|Earnings Date||Jan 29, 2021|
|Forward Dividend & Yield||2.96 (2.25%)|
|Ex-Dividend Date||Nov 12, 2020|
|1y Target Est||168.88|
Brian Garibaldi, JHU Biocontainment Unit Director, joins The Final Round to discuss his thoughts on the rising numbers of cases across the globe and the most recent developments in the vaccine race.
As cases rise globally, Sanofi and GlaxoSmithKline have agreed to provide 20 million vaccine doses to the WHO’s COVAX program and the U.S. has agreed to pay $347 million for 300,000 doses of Eli Lilly’s antibody drug. Yahoo Finance’s Anjalee Khemlani joins The Final Round to discuss the latest on the coronavirus.
Amgen (AMGN) is trading lower after third quarter earnings and could drop another 20 points in coming weeks.